Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
The efficacy of kinase inhibitors in treating cancer is limited by drug resistance; here it is shown that most human tumour cells can develop drug resistance through being exposed to one or more receptor tyrosine kinase ligands. BRAF/MET inhibitor to treat melanoma Targeted anticancer therapies are...
Saved in:
| Published in: | Nature (London) 2012-07, Vol.487 (7408), p.505-509 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|